First Anticoagulant Approved to Treat Symptomatic VTE in Pediatric Patients - Pulmonology Advisor
First Anticoagulant Approved to Treat Symptomatic VTE in Pediatric Patients Pulmonology Advisor
The FDA has approved Fragmin, a low molecular weight heparin, for the treatment of symptomatic venous thromboembolism to reduce the recurrence of VTE in ...
Comments
Post a Comment